Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J A TalcottP W Kantoff

Abstract

To assess complications of therapy for early (nonmetastatic) prostate cancer. A prospective study of a cohort of 279 men who sought treatment advice and completed required pretreatment forms. The measures were self-reported patient symptoms and other measures of quality of life before therapy and at 3 and 12 months afterward. Bowel and bladder symptoms were uncommon pretreatment. Patients frequently reported irritative bowel and bladder symptoms at 3 months after radiotherapy, although these subsided somewhat at 12 months. Substantial ("a lot") urinary incontinence and wearing of absorptive pads were reported by 11% and 35% at 12 months after surgery and varied little by age. Incontinence occurred after radiotherapy infrequently, and only in men more than 65 years old. Inadequate erections, present in one third of men pretreatment, were nearly universal at 3 months after surgery, although some improvement, primarily in men under 65 years of age, was evident at 12 months. Sexual dysfunction after radiotherapy increased less but continually through 12 months, suggesting that observed treatment-related differences would decline with further follow-up. External-beam radiotherapy of early prostate cancer is followed by bowel and bla...Continue Reading

Citations

Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J B MadalinskaF H Schröder
Jan 25, 2002·Cancer Control : Journal of the Moffitt Cancer Center·P Grise, S Thurman
Oct 27, 2001·Journal of General Internal Medicine·B G BokhourJ A Talcott
Apr 11, 2003·The Journal of Urology·David F PensonNeil K Aaronson
May 27, 2004·Current Urology Reports·Matthew R CooperbergPeter R Carroll
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Terri Kang JohnsonAnn S Hamilton
Sep 24, 2004·International Journal of Urology : Official Journal of the Japanese Urological Association·Shunichi NamikiYoichi Arai
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David C MillerJohn T Wei
Sep 6, 2005·Japanese Journal of Clinical Oncology·Shunichi NamikiYoichi Arai
Apr 1, 2005·International Journal of Cancer. Journal International Du Cancer·Ida J KorfageHarry J de Koning
Jul 12, 2005·The Journal of Urology·Wendy SiuJohn T Wei
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jack A Clark, James A Talcott
Nov 9, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Patrick O MonahanMichael Koch
Jul 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ronald C ChenJames A Talcott
Mar 16, 2012·Neurourology and Urodynamics·Karl-Dietrich SievertDiane K Newman
Oct 12, 2013·BJU International·James A TalcottAnthony L Zietman
May 21, 2014·Nature Reviews. Urology·Jonathan Bergman, Aaron Laviana
Oct 21, 1999·Journal of the National Cancer Institute·A L PotoskyM S Litwin
Mar 7, 2002·Cancer Practice·C Berterö
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D C WeberR Miralbell
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S HamiltonA L Potosky
Aug 30, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shabbir M H AlibhaiMurray D Krahn
Jan 6, 2005·Cancer Nursing·Terry Lynn Gall
Mar 1, 2006·Prostate Cancer and Prostatic Diseases·T L MulhollandK M Peters
Oct 31, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E J SmallD M Reese
Aug 3, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Masaharu IshiharaTomohiko Ichikawa
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James A TalcottAnthony V D'Amico
Oct 19, 2006·Journal of Psychosocial Oncology·Bert VoermanJozien Bensing
Dec 8, 2005·British Journal of Cancer·H InnesE Marshall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.